ANDROGEN DEPRIVATION THERAPY
Clinical trials for ANDROGEN DEPRIVATION THERAPY explained in plain language.
Never miss a new study
Get alerted when new ANDROGEN DEPRIVATION THERAPY trials appear
Sign up with your email to follow new studies for ANDROGEN DEPRIVATION THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo aims to boost prostate cancer treatment success
Disease control Recruiting nowThis early-stage trial is testing the safety and effectiveness of combining two medications, relugolix and enzalutamide, for men with high-risk, locally advanced prostate cancer. Participants will take these drugs before and after their standard treatment, which is either radiati…
Matched conditions: ANDROGEN DEPRIVATION THERAPY
Phase: PHASE1 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Can home workouts protect hearts of black prostate cancer patients?
Disease control Recruiting nowThis study is testing whether a 16-week home exercise program can improve heart health in Black men with prostate cancer who are receiving hormone therapy. Researchers will compare a group doing supervised virtual workouts with a group maintaining their usual activity. The goal i…
Matched conditions: ANDROGEN DEPRIVATION THERAPY
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
New hope for men suffering from cancer treatment hot flashes
Symptom relief Recruiting nowThis study is testing a drug called fezolinetant to see if it can safely reduce hot flashes in men with prostate cancer who are receiving hormone-blocking therapy. The drug is already approved for hot flashes in women. Researchers will measure how well it reduces the frequency an…
Matched conditions: ANDROGEN DEPRIVATION THERAPY
Phase: PHASE2 • Sponsor: University of Vermont • Aim: Symptom relief
Last updated Apr 03, 2026 18:10 UTC
-
New hope for men suffering debilitating hot flashes from cancer treatment
Symptom relief Recruiting nowThis study is testing whether a medication called fezolinetant can safely reduce the frequency and severity of hot flashes in men with prostate cancer who are undergoing hormone-blocking therapy. Researchers will compare the drug to a placebo in 60 participants over 4 weeks to se…
Matched conditions: ANDROGEN DEPRIVATION THERAPY
Phase: PHASE2 • Sponsor: Shehzad Basaria, M.D. • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC
-
Needles vs. night sweats: ancient practice tested for modern cancer side effect
Symptom relief Recruiting nowThis small pilot study is testing whether acupuncture is a practical and helpful way to reduce hot flashes in men receiving hormone therapy for prostate cancer. 24 men will be randomly assigned to start acupuncture right away or after a waiting period, while all receive standard …
Matched conditions: ANDROGEN DEPRIVATION THERAPY
Phase: NA • Sponsor: Inova Health Care Services • Aim: Symptom relief
Last updated Feb 27, 2026 15:19 UTC